381 filings
Page 8 of 20
6-K
BNTX
BioNTech SE
16 Feb 22
Current report (foreign)
9:00am
SC 13G/A
BNTX
BioNTech SE
14 Feb 22
BioNTech SE / Medine GmbH ownership change
4:23pm
6-K
BNTX
BioNTech SE
11 Feb 22
Current report (foreign)
4:54pm
SC 13G/A
BNTX
BioNTech SE
11 Feb 22
BioNTech SE / ATHOS KG ownership change
12:00am
6-K
BNTX
BioNTech SE
9 Feb 22
Current report (foreign)
7:53am
6-K
BNTX
BioNTech SE
3 Feb 22
The curious case of the BioNTech priority review voucher
9:21am
6-K
BNTX
BioNTech SE
1 Feb 22
Current report (foreign)
5:06pm
6-K
BNTX
BioNTech SE
25 Jan 22
Current report (foreign)
9:00am
6-K
BNTX
BioNTech SE
24 Jan 22
Current report (foreign)
4:59pm
6-K
BNTX
BioNTech SE
11 Jan 22
BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants
7:41am
6-K
BNTX
BioNTech SE
11 Jan 22
Current report (foreign)
7:34am
6-K
BNTX
BioNTech SE
10 Jan 22
BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
8:58am
6-K
BNTX
BioNTech SE
5 Jan 22
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
7:30am
6-K
BNTX
BioNTech SE
3 Jan 22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
4:38pm
6-K
BNTX
BioNTech SE
20 Dec 21
Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply
7:21am
6-K
BNTX
BioNTech SE
17 Dec 21
Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine
9:21am
6-K
BNTX
BioNTech SE
17 Dec 21
Current report (foreign)
9:13am
6-K
BNTX
BioNTech SE
9 Dec 21
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
4:54pm
6-K
BNTX
BioNTech SE
8 Dec 21
Current report (foreign)
5:09pm
6-K
BNTX
BioNTech SE
8 Dec 21
Pfizer and BioNTech Provide Update on Omicron Variant
7:57am